Rabbit Recombinant Monoclonal p18 INK4c/CDKN2C antibody. Carrier free. Suitable for IP, WB, ICC/IF, IHC-P and reacts with Human, Mouse, Rat samples.
pH: 7.2 - 7.4
Constituents: PBS
IP | WB | ICC/IF | IHC-P | |
---|---|---|---|---|
Human | Tested | Tested | Tested | Tested |
Mouse | Expected | Tested | Expected | Expected |
Rat | Expected | Tested | Expected | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Interacts strongly with CDK6, weakly with CDK4. Inhibits cell growth and proliferation with a correlated dependence on endogenous retinoblastoma protein RB.
CDKN6, CDKN2C, Cyclin-dependent kinase 4 inhibitor C, Cyclin-dependent kinase 6 inhibitor, p18-INK4c, p18-INK6
Rabbit Recombinant Monoclonal p18 INK4c/CDKN2C antibody. Carrier free. Suitable for IP, WB, ICC/IF, IHC-P and reacts with Human, Mouse, Rat samples.
pH: 7.2 - 7.4
Constituents: PBS
ab232631 is the carrier-free version of Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
P18 INK4c also known as CDKN2C is a cyclin-dependent kinase inhibitor that plays an important role in cell cycle regulation. It is a member of the INK4 family and carries a molecular mass of approximately 18 kDa. This protein actively inhibits the activity of CDK4 and CDK6 key kinases that drive the transition from the G1 to S phase in the cell cycle. p18 INK4c is expressed in various tissues with notable expression in the adrenal gland kidney and the nervous system.
P18 INK4c functions as a regulator by acting as a part of the complex that controls cell proliferation. It ensures that cells do not proceed through the G1/S checkpoint inappropriately maintaining proper cell cycle control. This protein serves as a brake in the cell cycle by binding to CDK4/6 thereby preventing their interaction with D-type cyclins and subsequent cell cycle progression.
P18 INK4c is an important component of the retinoblastoma (Rb) pathway as well as the p16INK4a-pRB pathway. These pathways are important for negative regulation of the cell cycle. In these pathways p18 INK4c inhibits CDK4 and CDK6 which are kinases needed to phosphorylate the Rb protein a pivotal step for cell cycle progression. The regulation of these pathways plays a part in processes like cellular senescence and differentiation.
P18 INK4c is associated with various types of cancer including glioma and breast cancer. Alterations in the expression or function of p18 INK4c can lead to unchecked cell proliferation and tumorigenesis. It often interacts with proteins such as CDK4 and CDK6 in these contexts where dysregulation may contribute to the development and progression of the diseases. Understanding p18 INK4c's role could provide insights into potential therapeutic strategies for these cancers.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using the same antibody clone in a different buffer formulation (Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239).
Lanes 1-4: Merged signal (red and green). Green - Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239 observed at 18 kDa. Red - loading control Anti-GAPDH antibody [6C5] - Loading Control ab8245 observed at 37 kDa.
Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239 Anti-p18 INK4c/CDKN2C antibody [EPR15891] was shown to specifically react with Cyclin Dependent Kinase Inhibitor 2C in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265031 (knockout cell lysate ab257887) was used. Wild-type and Cyclin Dependent Kinase Inhibitor 2C knockout samples were subjected to SDS-PAGE. Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239 and Anti-GAPDH antibody [6C5] - Loading Control (Anti-GAPDH antibody [6C5] - Loading Control ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-p18 INK4c/CDKN2C antibody [EPR15891] (Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239) at 1/1000 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: CDKN2C knockout HeLa cell lysate at 20 µg
Lane 3: Rat kidney cell lysate at 20 µg
Lane 4: Jurkat cell lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 18 kDa
Western blot analysis of immunoprecipitation pellet from HeLa lysate immunoprecipitated using Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239 at 1/30 dilution.
Secondary: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239).
All lanes: Immunoprecipitation - Anti-p18 INK4c/CDKN2C antibody [EPR15891] (Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239)
Predicted band size: 18 kDa
Immunofluorescent analysis of HeLa cells (4% Paraformaldehyde-fixed, 0.1% tritonX-100 permeabilized) labeling p18 INK4C/CDKN2C with Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239 at 1/100 dilution (5μg/mL) followed by Goat anti rabbit IgG (AlexaFluor® 488) (Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) secondary at 1/200 dilution and counter-stained with DAPI (blue).
Negative controls: anti-p18 INK4C/CDKN2C at 1/100 dilution, Secondary ab (Goat anti mouse IgG (Alexa Fluor®594)) at 1/400 dilution.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239).
Immunohistochemical analysis of paraffin-embedded Human brain tissue labeling p18 INK4C/CDKN2C with Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239 at 1/50 dilution followed by pre-diluted HRP Polymer for Rabbit/Mouse IgG secondary antibody and counter-stained with Hematoxylin. (inset: negative control).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239).
Heat mediated antigen retrieval was performed with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
Immunohistochemical analysis of paraffin-embedded Human glioma tissue labeling p18 INK4C/CDKN2C with Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239 at 1/50 dilution followed by pre-diluted HRP Polymer for Rabbit/Mouse IgG secondary antibody and counter-stained with Hematoxylin. (inset: negative control).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-p18 INK4c/CDKN2C antibody [EPR15891] ab192239).
Heat mediated antigen retrieval was performed with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com